Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01087177 · ClinicalTrials.gov registry record · NA
Effectiveness of Pedialink CEASE Module
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 647
- Enrollment target
NCT01087177: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01087177 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 647 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01087177, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 647 participants
- Enrollment target
Study Summary
The study involves the testing of a Pedialink module through parent exit interviews in one intervention practice and one control practice. Pedialink is the American Academy of Pediatrics' online home for continuous professional development. The intervention site will complete the Pedialink module and the control site will be given routine tobacco control materials. We will measure changes in practice patterns in the two pediatric practices following the implementation of the online training. At each of these practices, the parents or guardians of children seen by the practice will be surveyed for a one week period before, and a one week period six weeks after either using the online training module (intervention) or being given routine tobacco materials (control). A follow-up telephone survey will be given to some parents at 3-months. Those given the telephone survey are parents or guardians who smoke or parents or guardians who live with a smoker and are surveyed at the second time-point. We hypothesize that intervention practices will have higher rates of screening for home and car no-smoking rules and higher rates of advising for home and car no-smoking rules.
Interventions
- OTHER Exposure to practice that has been trained in Pedialink CEASE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 647 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01087177
The ClinicalTrials.gov registry entry for NCT01087177 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 647 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exposure to practice that has been trained in Pedialink CEASE is the first listed.
NCT01087177 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01087177 about?
NCT01087177 is a clinical study titled "Effectiveness of Pedialink CEASE Module". The study involves the testing of a Pedialink module through parent exit interviews in one intervention practice and one control practice. Pedialink is the American Academy of Pediatrics' online home for continuous professional development. The intervention site will complete the Pedialink module an...
What is the current status of trial NCT01087177?
This trial is currently completed. It is a NA study. The enrollment target is 647 participants. The study started on 2010-03. Estimated completion is 2011-02.
What interventions are being tested in trial NCT01087177?
The interventions under investigation include: Exposure to practice that has been trained in Pedialink CEASE (OTHER).
Who is sponsoring clinical trial NCT01087177?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.